Skip to main content

Table 1 Clinical characteristics of the study population

From: Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease

 

Disease-free controls

Untreated GD

GD in remission

N (F/M)

14 (9/5)

54 (38/16)

12 (9/3)

Age (years)

31.57±6.81

38.87±11.30

47.55±11.61*

FT3 (pmol/L)

4.62±0.51#

26.90±14.17*

4.13±0.49#

FT4 (pmol/L)

13.76±1.57#

41.44±28.87*

13.47±1.10#

TSH (mIU/L)

1.93±1.17#

0.32±2.33*

2.38±0.95#

TRAb (IU/L)

0.46±0.24#

17.15±12.88*

0.75±0.13#

TPOAb (IU/mL)

19.02±68.15#

435.77±366.92*

274.38±157.71

TgAb (IU/mL)

6.01±13.57#

209.71±275.97*

74.25±61.31

  1. * Compared to disease-free controls, P < 0.001
  2. # Compared to untreated GD, P < 0.001